The rate of e-bike and powered scooter injuries surged between 2019 and 2022– by 293 percent and 88 percent, respectively, according to a new study at Columbia University Mailman School of Public…
:max_bytes(150000):strip_icc()/Health-GettyImages-1372618759-v2-06688f9bd9fc4188abe542650810aa6b.jpg "Study Shows Rates of E-Bike Injuries Rise Fourfold and Powered Scooter Injuries Nearly Double")
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes. With this novel treatment proving to be very effective, researchers are curious to know more about what other…
Clinical trial results from St. Jude Children’s Research Hospital demonstrate benefits to using genomics and early treatment response to guide risk classification of children with B-cell acute lymphoblastic leukemia (B-ALL). Traditionally, the intensity…
New randomized study of 168 people investigates the neurochemical underpinnings of the placebo-effect New findings argue against a direct causal role for dopamine during the experience of a treatment effect in the…
Guideline highlights: The American Heart Association and the American College of Cardiology joint guideline addressing cardiovascular evaluation and management of patients before, during and after noncardiac surgery reviews a decade of new…
A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the nation offered any form of medication for…
What: Cancer incidence trends in 2021 largely returned to what they were before the COVID-19 pandemic, according to a study by researchers at the National Institutes of Health (NIH). However, there was little…
Despite its importance for mathematics, the neuronal basis of the number zero in the human brain was previously unknown. Researchers from the University Hospital Bonn (UKB), the University of Bonn and the…
Many human medications can directly inhibit the growth and alter the function of the bacteria that constitute our gut microbiome. EMBL Heidelberg researchers have now discovered that this effect is reduced when…
Researchers at ETH Zurich have used a drug screening platform they developed to show that an antidepressant, currently on the market, kills tumour cells in the dreaded glioblastoma – at least in…